Review:
Liquid Biopsy In Cancer Detection
overall review score: 4.5
⭐⭐⭐⭐⭐
score is between 0 and 5
Liquid biopsy in cancer detection is a minimally invasive diagnostic method that analyzes circulating tumor DNA (ctDNA), circulating tumor cells (CTCs), or other biomarkers present in body fluids such as blood, saliva, or urine. It enables early detection, monitoring of treatment response, and detection of cancer recurrence without the need for traditional tissue biopsies, which can be invasive and risky.
Key Features
- Non-invasive sampling through blood or other body fluids
- Ability to detect genetic mutations and molecular alterations associated with cancers
- Real-time monitoring of disease progression and treatment effectiveness
- Potential for early diagnosis before clinical symptoms appear
- Facilitates personalized medicine by identifying specific genetic profiles
Pros
- Minimally invasive compared to traditional biopsies
- Allows for frequent monitoring to track treatment response
- Can detect cancer at an earlier stage when intervention is more effective
- Reduces patient discomfort and risk of complications
- Enables personalized treatment planning based on molecular insights
Cons
- Current sensitivity may vary depending on cancer type and stage
- Potential for false positives/negatives due to biological variations in ctDNA levels
- Limited availability and high costs in some regions
- Requires sophisticated laboratory equipment and expertise
- Not yet universally standardized across all types of cancers